Vetter, a CDMO that specialises in the aseptic filling of syringes, cartridges and vials, has completed the first phase of the construction of a new, multi-functional building in Ravensburg, Germany.
The €26m, 8,500m2 building, which will house hi-tech laboratories and workplaces for Vetter Development Services, as well as a secure data centre, is expected to be fully operational by the beginning of 2016.
The investment is a direct result of increased demand by customers for support in drug development, as well as the need for enhanced company-wide IT systems, the company said.
Through facilities located in Chicago, US, and Ravensburg, Vetter Development Service offers support in all phases of clinical drug development, including pharmaceutical analysis, process development, and clinical trial supply. The new six-storey building will contain labs for microbiological analysis, and spare capacity to meet future growth needs such as additional cleanrooms and labs.
The new data centre will have enhanced security systems and a safety cell that protects technology and data from external physical hazards, as well as a state-of-the-art gas extinguishing system to minimise damage in the event of an emergency.
'With this new building, we are addressing the growing demand of our customers in the area of clinical drug development and manufacturing,' said Thomas Otto, a Vetter Managing Director. 'Furthermore, with the installation of the sophisticated IT systems, Vetter will be well-prepared to meet future challenges that present themselves.'
